The orthopedic biomaterials market size has grown rapidly in recent years. It will grow from $22.6 billion in 2025 to $25.9 billion in 2026 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to aging population growth, rising orthopedic injuries, expansion of joint replacement surgeries, availability of metallic implants, hospital infrastructure development.
The orthopedic biomaterials market size is expected to see strong growth in the next few years. It will grow to $36.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growth in sports injuries, demand for personalized implants, increasing osteoarthritis prevalence, advancements in composite biomaterials, rising healthcare expenditure. Major trends in the forecast period include rising use of bioactive materials, growing demand for joint replacement solutions, increased adoption of lightweight implants, expansion of minimally invasive orthopedic procedures, focus on long-term implant durability.
The rise in the incidence of musculoskeletal disorders is increasingly supporting the expansion of the orthopedic biomaterials market. Musculoskeletal disorders cause fractures, inflammation, pain, and discomfort in joints, ligaments, and tendons, often leading to movement limitations and disability. The burden of musculoskeletal conditions increases significantly with age, as degenerative changes become more common in older populations. For example, in January 2024, according to GOV.UK, a UK-based government department, 18.4% of individuals aged 16 years and older reported having a long-term musculoskeletal condition in 2023, up from 17.6% in 2022. Consequently, the growing incidence of musculoskeletal disorders is reinforcing demand for orthopedic biomaterials.
Leading companies operating in the orthopedic biomaterials market are focusing on innovative products, such as tendon fixation devices, to drive market revenues. A tendon fixation device is an orthopedic implant used to secure tendons, ligaments, or soft tissue to bone during surgical procedures. For example, in June 2023, Acuitive Technologies Inc., a US-based developer of orthopedic biomaterial technologies, launched a new tendon fixation device for anterior cruciate ligament repair. The device features a tendon-friendly spiral thread made from Citregen, a next-generation resorbable material engineered to support natural healing while reducing chronic inflammation commonly associated with other biodegradable devices.
In September 2023, Enovis, a US-based medical technology company, acquired Lima Corporate for $847 million. Enovis expects the acquisition to deliver several strategic benefits, including the opportunity to expand its successful reconstruction portfolio and strengthen its global presence. The transaction is anticipated to support improved financial performance through cross-selling revenue opportunities and cost efficiencies. Lima Corporate is an Italy-based manufacturer of orthopedic biomaterials.
Major companies operating in the orthopedic biomaterials market are Medtronic PLC, Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, NuVasive, Wright Medical Group N.V., Orthofix Medical Inc., Acelity, Conmed Corporation, Aesculap, Seaspine Holdings Corporation, Bone Support AB, Bioventus, K2M Group Holdings Inc., MTF Biologics, Amedica Corporation, TPL Biomed, Fidia Farmaceutici S.p.A., OsteoRemedies, Xtant Medical, RTI Surgical Holdings Inc., LifeNet Health, VIVEX Biologics, DJO Global, MedShape, Evonik Industries AG, Heraeus Medical, 3M Company, Collagen Solutions plc.
North America was the largest region in the orthopedic biomaterials market in 2025. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the orthopedic biomaterials market by increasing costs of imported metals, ceramics, and polymers used in implants and fixation systems. Joint replacement and bio-resorbable fixation segments are most affected, particularly in North America and Europe. Positively, tariffs are driving localized production, material innovation, and supplier diversification to stabilize pricing and supply chains.
The orthopedic biomaterials market research report is one of a series of new reports that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with a orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. This orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Orthopedic biomaterials are substances developed to be implanted in the human body as parts of medical devices designed to perform specific biological functions by replacing or repairing different tissues such as bones, cartilage, ligaments, tendons, and others.
The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metals, and composites. Polymers used as orthopedic biomaterials are intended for implantation into the human body as functional components. The applications include orthopedic implants, joint replacement or reconstruction, bioresorbable tissue fixation, orthobiologics, and viscosupplementation, and these materials are used by end users such as hospitals, clinics, and others.
The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The orthopedic biomaterials market size is expected to see strong growth in the next few years. It will grow to $36.67 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growth in sports injuries, demand for personalized implants, increasing osteoarthritis prevalence, advancements in composite biomaterials, rising healthcare expenditure. Major trends in the forecast period include rising use of bioactive materials, growing demand for joint replacement solutions, increased adoption of lightweight implants, expansion of minimally invasive orthopedic procedures, focus on long-term implant durability.
The rise in the incidence of musculoskeletal disorders is increasingly supporting the expansion of the orthopedic biomaterials market. Musculoskeletal disorders cause fractures, inflammation, pain, and discomfort in joints, ligaments, and tendons, often leading to movement limitations and disability. The burden of musculoskeletal conditions increases significantly with age, as degenerative changes become more common in older populations. For example, in January 2024, according to GOV.UK, a UK-based government department, 18.4% of individuals aged 16 years and older reported having a long-term musculoskeletal condition in 2023, up from 17.6% in 2022. Consequently, the growing incidence of musculoskeletal disorders is reinforcing demand for orthopedic biomaterials.
Leading companies operating in the orthopedic biomaterials market are focusing on innovative products, such as tendon fixation devices, to drive market revenues. A tendon fixation device is an orthopedic implant used to secure tendons, ligaments, or soft tissue to bone during surgical procedures. For example, in June 2023, Acuitive Technologies Inc., a US-based developer of orthopedic biomaterial technologies, launched a new tendon fixation device for anterior cruciate ligament repair. The device features a tendon-friendly spiral thread made from Citregen, a next-generation resorbable material engineered to support natural healing while reducing chronic inflammation commonly associated with other biodegradable devices.
In September 2023, Enovis, a US-based medical technology company, acquired Lima Corporate for $847 million. Enovis expects the acquisition to deliver several strategic benefits, including the opportunity to expand its successful reconstruction portfolio and strengthen its global presence. The transaction is anticipated to support improved financial performance through cross-selling revenue opportunities and cost efficiencies. Lima Corporate is an Italy-based manufacturer of orthopedic biomaterials.
Major companies operating in the orthopedic biomaterials market are Medtronic PLC, Johnson & Johnson, Stryker Corporation, Zimmer Biomet, Smith & Nephew, NuVasive, Wright Medical Group N.V., Orthofix Medical Inc., Acelity, Conmed Corporation, Aesculap, Seaspine Holdings Corporation, Bone Support AB, Bioventus, K2M Group Holdings Inc., MTF Biologics, Amedica Corporation, TPL Biomed, Fidia Farmaceutici S.p.A., OsteoRemedies, Xtant Medical, RTI Surgical Holdings Inc., LifeNet Health, VIVEX Biologics, DJO Global, MedShape, Evonik Industries AG, Heraeus Medical, 3M Company, Collagen Solutions plc.
North America was the largest region in the orthopedic biomaterials market in 2025. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the orthopedic biomaterials market by increasing costs of imported metals, ceramics, and polymers used in implants and fixation systems. Joint replacement and bio-resorbable fixation segments are most affected, particularly in North America and Europe. Positively, tariffs are driving localized production, material innovation, and supplier diversification to stabilize pricing and supply chains.
The orthopedic biomaterials market research report is one of a series of new reports that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with a orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. This orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Orthopedic biomaterials are substances developed to be implanted in the human body as parts of medical devices designed to perform specific biological functions by replacing or repairing different tissues such as bones, cartilage, ligaments, tendons, and others.
The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metals, and composites. Polymers used as orthopedic biomaterials are intended for implantation into the human body as functional components. The applications include orthopedic implants, joint replacement or reconstruction, bioresorbable tissue fixation, orthobiologics, and viscosupplementation, and these materials are used by end users such as hospitals, clinics, and others.
The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Orthopedic Biomaterials Market Characteristics
3. Orthopedic Biomaterials Market Supply Chain Analysis
4. Global Orthopedic Biomaterials Market Trends and Strategies
5. Orthopedic Biomaterials Market Analysis of End Use Industries
7. Global Orthopedic Biomaterials Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Orthopedic Biomaterials Total Addressable Market (TAM) Analysis for the Market
9. Orthopedic Biomaterials Market Segmentation
10. Orthopedic Biomaterials Market Regional and Country Analysis
11. Asia-Pacific Orthopedic Biomaterials Market
12. China Orthopedic Biomaterials Market
13. India Orthopedic Biomaterials Market
14. Japan Orthopedic Biomaterials Market
15. Australia Orthopedic Biomaterials Market
16. Indonesia Orthopedic Biomaterials Market
17. South Korea Orthopedic Biomaterials Market
18. Taiwan Orthopedic Biomaterials Market
19. South East Asia Orthopedic Biomaterials Market
20. Western Europe Orthopedic Biomaterials Market
21. UK Orthopedic Biomaterials Market
22. Germany Orthopedic Biomaterials Market
23. France Orthopedic Biomaterials Market
24. Italy Orthopedic Biomaterials Market
25. Spain Orthopedic Biomaterials Market
26. Eastern Europe Orthopedic Biomaterials Market
27. Russia Orthopedic Biomaterials Market
28. North America Orthopedic Biomaterials Market
29. USA Orthopedic Biomaterials Market
30. Canada Orthopedic Biomaterials Market
31. South America Orthopedic Biomaterials Market
32. Brazil Orthopedic Biomaterials Market
33. Middle East Orthopedic Biomaterials Market
34. Africa Orthopedic Biomaterials Market
36. Orthopedic Biomaterials Market Competitive Landscape and Company Profiles
37. Orthopedic Biomaterials Market Other Major and Innovative Companies
40. Orthopedic Biomaterials Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Orthopedic Biomaterials Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses orthopedic biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for orthopedic biomaterials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthopedic biomaterials market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Material Type: Ceramics And Bioactive Glasses; Calcium Phosphate Cements; Polymers; Metal; Composites2) By Application: Orthopedic Implants; Joint Replacement/Reconstruction; Bio-Resorbable Tissue Fixation; Other Applications
3) By End-User: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Ceramics And Bioactive Glasses: Bioactive Glasses; Alumina Ceramics; Zirconia Ceramics2) By Calcium Phosphate Cements: Hydroxyapatite (HA) Cements; Tricalcium Phosphate (TCP) Cements; Biphasic Calcium Phosphate Cements
3) By Polymers: Polyethylene (PE); Polymethyl Methacrylate (PMMA); Polyetheretherketone (PEEK)
4) By Metal: Titanium Alloys; Stainless Steel; Cobalt-Chromium Alloys
5) By Composites: Fiber-Reinforced Composites; Polymer-Ceramic Composites; Metal-Ceramic Composites
Companies Mentioned: Medtronic PLC; Johnson & Johnson; Stryker Corporation; Zimmer Biomet; Smith & Nephew; NuVasive; Wright Medical Group N.V.; Orthofix Medical Inc.; Acelity; Conmed Corporation; Aesculap; Seaspine Holdings Corporation; Bone Support AB; Bioventus; K2M Group Holdings Inc.; MTF Biologics; Amedica Corporation; TPL Biomed; Fidia Farmaceutici S.p.A.; OsteoRemedies; Xtant Medical; RTI Surgical Holdings Inc.; LifeNet Health; VIVEX Biologics; DJO Global; MedShape; Evonik Industries AG; Heraeus Medical; 3M Company; Collagen Solutions plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Orthopedic Biomaterials market report include:- Medtronic PLC
- Johnson & Johnson
- Stryker Corporation
- Zimmer Biomet
- Smith & Nephew
- NuVasive
- Wright Medical Group N.V.
- Orthofix Medical Inc.
- Acelity
- Conmed Corporation
- Aesculap
- Seaspine Holdings Corporation
- Bone Support AB
- Bioventus
- K2M Group Holdings Inc.
- MTF Biologics
- Amedica Corporation
- TPL Biomed
- Fidia Farmaceutici S.p.A.
- OsteoRemedies
- Xtant Medical
- RTI Surgical Holdings Inc.
- LifeNet Health
- VIVEX Biologics
- DJO Global
- MedShape
- Evonik Industries AG
- Heraeus Medical
- 3M Company
- Collagen Solutions plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 25.9 Billion |
| Forecasted Market Value ( USD | $ 36.67 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
